Two Years Later: Is What I Told the Wall Street Journal About Psychedelics Still True?

Two years after my Wall Street Journal quote on psychedelic risks, the hype is giving way to nuance. This article explores what’s happened since, emerging research on ketamine’s risks for trauma survivors, and why trauma-informed care is essential as psychedelic therapy moves forward.